| EXOSX | RERAX | EXOSX / RERAX | |
| Total Expense Ratio | 0.76 | 1.57 | 48% |
| Annual Report Gross Expense Ratio | 0.79 | 1.57 | 50% |
| Fund Existence | 23 years | 24 years | - |
| Gain YTD | 15.176 | 11.204 | 135% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 330M | 134B | 0% |
| Annual Yield % from dividends | 1.12 | 0.22 | 512% |
| Returns for 1 year | 13.97 | 9.94 | 141% |
| Returns for 3 years | 42.58 | 23.04 | 185% |
| Returns for 5 years | 22.43 | -11.51 | -195% |
| Returns for 10 years | 104.83 | 30.17 | 347% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IYSIX | 22.97 | 0.11 | +0.48% |
| Nomura Small Cap Growth Institutional | |||
| VGHCX | 206.29 | 0.59 | +0.29% |
| Vanguard Health Care Inv | |||
| BGESX | 14.67 | 0.04 | +0.27% |
| Baillie Gifford International Growth I | |||
| BPLEX | 10.55 | 0.02 | +0.19% |
| Boston Partners Long/Short Equity Inv | |||
| STRSX | 26.82 | N/A | N/A |
| Sterling Capital Special Opps R6 | |||